China, Russia To Do Final Phase Tests Of Cuban Diabetes Foot Ulcer Drug
This article was originally published in PharmAsia News
Executive Summary
China and Russia are to serve as sites for Phase III trials of a diabetes-related drug developed by Cuba, according to the island nation's official newspaper.